MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7

Bing Yu1,2, Xuezhong Liu3, Hong Chang4

  • 1Department of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University, Jinan, China.

Minerva Medica
|November 10, 2016
PubMed
Abstract

Insights

MicroRNA-143 (miR-143) acts as a tumor suppressor in colorectal cancer (CRC) by inhibiting matrix metalloproteinase 7 (MMP7). Lower miR-143 levels correlate with higher MMP7 expression, promoting CRC progression.

Area of Science:

  • Molecular biology
  • Oncology
  • Gene regulation

Background:

  • MicroRNAs (miRNAs) are crucial in cancer development.
  • miR-143 functions as a tumor suppressor, with decreased levels in colorectal cancer (CRC).
  • The precise mechanism of miR-143 in CRC pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the role of miR-143 in colorectal cancer.
  • To identify and validate the target genes of miR-143 in CRC.
  • To elucidate the functional impact of the miR-143/MMP7 interaction on CRC progression.

Main Methods:

  • Computational target prediction (TargetScan) and experimental validation (luciferase reporter assay) were employed to identify miR-143 targets.
  • Overexpression of miR-143 in CRC cells followed by quantitative real-time PCR (qRT-PCR) and western blot analysis to assess target gene expression.
  • Analysis of matrix metalloproteinase 7 (MMP7) expression in CRC tissues and cell lines, and its correlation with miR-143 levels.
  • Assessment of MMP7's effect on CRC cell proliferation and invasion.

Main Results:

  • TargetScan and luciferase assays confirmed MMP7 as a direct target of miR-143.
  • Increased miR-143 expression significantly reduced both mRNA and protein levels of MMP7 in CRC cells.
  • MMP7 expression was elevated in CRC tissues and cell lines, showing an inverse correlation with miR-143 levels.
  • Overexpression of MMP7 counteracted the inhibitory effects of miR-143 on CRC cell proliferation and invasion.

Conclusions:

  • miR-143 functions as a tumor suppressor in colorectal cancer.
  • This tumor-suppressive activity is mediated through the direct targeting of MMP7.
  • The miR-143/MMP7 axis represents a potential therapeutic target for colorectal cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K